Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 90 EP applications Wilhelmus Johannes Wytenburg has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 01, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12709201

CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF CONDENSED AZACYCLES ( CANNABINOID RECEPTOR MODULATORS)

IPC classification:
A61K 31/416, C07D 403/04, A61P 29/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12716763

CANNABINOID RECEPTOR MODULATORS

IPC classification:
A61K 31/661, A61K 31/497, A61K 31/4439, A61K 31/416, C07F 9/09, C07D 405/14, C07D 403/04, C07D 401/14, C07D 401/04, C07D 231/54, A61P 29/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12786332

QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/517, C07D 493/04, C07D 405/12, A61P 35/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12792550

TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE

IPC classification:
A61K 31/395, C07F 9/6584, A61P 35/00, A61P 29/00, A61P 9/10
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12844804

PAK INHIBITORS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS

IPC classification:
A61K 31/519, C07D 471/04, C07D 405/14, C07D 403/10, A61P 35/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION REFUSED
EP12845870

PAK INHIBITORS FOR THE TREATMENT OF FRAGILE X SYNDROME

IPC classification:
A61K 31/519, C07D 471/04, C07D 401/10, A61P 25/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12784666

5-(PYRIDIN-2-YL-AMINO)-PYRAZINE-2-CARBONITRILE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61K 31/497, C07D 401/14, C07D 401/12, A61P 35/00
Applicant:
Cancer Research Technology Ltd
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12859248

GUANINE ANALOGS AS TELOMERASE SUBSTRATES AND TELOMERE LENGTH AFFECTORS

IPC classification:
A61K 31/688, A61K 31/685, A61K 31/683, A61K 31/675, C07F 9/6561, A61P 35/04, A61P 35/02, A61P 35/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13738359

BENZOHETEROCYCLIC COMPOUNDS AND USE THEREOF

IPC classification:
A61K 31/433, A61K 31/425, A61K 31/42, A61K 31/41, C07D 285/14, C07D 277/62, C07D 263/54, C07D 231/54, C07D 209/02, A61P 35/00, A61P 29/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The patent has been granted
EP12787319

MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO

IPC classification:
A61K 31/496, C07D 241/04, A61P 9/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14173149

Therapeutic compounds

IPC classification:
A61K 31/05, C07C 271/44, C07C 39/06, C07C 37/055, A61P 25/20
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13704701

MORPHOLINOALKYL FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE

IPC classification:
A61K 31/42, C07D 265/30, A61P 37/00, A61P 29/00, A61P 25/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13752050

SULFONAMIDE COMPOUNDS AND USES AS TNAP INHIBITORS

IPC classification:
A61K 31/44, C07D 401/12, C07D 215/38, C07D 213/74, A61P 19/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Agent:
Dr Nicola Elliott, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13709994

3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61K 31/506, A61K 31/496, A61K 31/4725, A61K 31/472, C07D 487/10, C07D 487/08, C07D 487/04, C07D 405/12, C07D 401/14, C07D 401/12, C07D 401/10, C07D 401/04, C07D 217/16, C07D 217/14, A61P 35/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13768915

PHENYL-UREA AND PHENYL-CARBAMATE DERIVATIVES AS INHIBITORS OF PROTEIN AGGREGATION

IPC classification:
A61K 31/27, A61K 31/17
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13773141

PROTEIN KINASE C INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/535, A61K 31/505, A61K 31/445, A01N 43/40
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13723910

5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF

IPC classification:
A61K 31/506, C07D 401/12, A61P 35/00
Applicant:
Cancer Research Technology Ltd
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13729851

TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE

IPC classification:
A61K 31/5375, A61K 31/265, C07D 295/104, C07D 207/02, C07C 235/14, A61P 25/00, A61P 17/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14182803

Modulators of the prostacyclin (PG12) receptor useful for the treatment of disorders related thereto

IPC classification:
A61K 31/27, A61K 31/17, C07C 275/18, C07C 271/08, A61P 43/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13816903

PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS

IPC classification:
A61K 31/122, A23L 1/30
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The patent has been granted
EP13820320

DI-AND TRI-HETEROARYL DERIVATIVES AS INHIBITORS OF PROTEIN AGGREGATION

IPC classification:
A61K 31/496
Applicant:
UCB Biopharma SPRL
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The patent has been granted
EP13756971

METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS

IPC classification:
A61K 31/5375, A61K 31/225, A61K 9/28, A61P 29/00, A61P 25/00, A61P 17/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13759076

ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF

IPC classification:
A61K 31/5375, A61K 31/225, A61K 9/28, A61K 9/16, A61P 29/00, A61P 25/00, A61P 17/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13756261

ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF

IPC classification:
A61K 31/5375, A61K 31/225, A61K 9/28, A61K 9/16, A61P 29/00, A61P 25/00, A61P 17/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13805533

COMBINATION THERAPY USING BELINOSTAT AND TRABECTEDIN

IPC classification:
A61K 45/06, A61K 31/4995, A61K 31/196
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13853588

COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE

IPC classification:
A61K 39/00, A61K 31/4152
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13855289

HYDRAZINYL-INDOLE COMPOUNDS AND CONJUGATES

IPC classification:
C07D 403/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13859485

INHIBITOR OF APOPTOSIS PROTEIN (IAP) ANTAGONISTS

IPC classification:
A61K 31/5365, C07D 498/04, C07D 487/04, A61P 35/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Agent:
HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13812297

PROTEIN KINASE C INHIBITORS AND USES THEREOF

IPC classification:
C07D 455/02
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14701137

BIPHENYL-ETHYL-PYRROLIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR MODULATORS FOR THE TREATMENT OF COGNITIVE DISORDERS

IPC classification:
A61K 31/41, A61K 31/4025, A61K 31/40, C07D 295/14, C07D 257/04, A61P 37/08, A61P 25/28, A61P 25/24, A61P 25/18, A61P 25/08, A61P 25/04, A61P 3/04
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The patent has been granted
EP15156493

Combination therapy using an HDAC inhibitor and Vincristine for treating cancer

IPC classification:
A61K 45/06, A61K 33/24, A61K 31/7076, A61K 31/7068, A61K 31/706, A61K 31/573, A61K 31/555, A61K 31/519, A61K 31/517, A61K 31/513, A61K 31/475, A61K 31/4745, A61K 31/337, A61K 31/24, A61K 31/198, A61K 31/196, A61K 31/18, A61K 31/138, A61P 35/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14729498

PROTEIN KINASE C INHIBITORS AND USES THEREOF

IPC classification:
A61P 35/00, A61K 31/437, C07D 471/04
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14725519

FLUORO-PERHEXILINE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61P 9/04, A61K 31/445, C07D 211/38
Applicant:
The University Court of The University of Aberdeen
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14733041

CORTICOSTEROID COMPOSITIONS

IPC classification:
A61K 31/58, A61K 31/573, A61K 31/57, A61K 31/56, A61K 47/14, A61K 9/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14735642

N-(4-HYDROXY-4-METHYL-CYCLOHEXYL)-4-PHENYL-BENZENESULFONAMIDES AND N-(4-HYDROXY-4-METHYL-CYCLOHEXYL)-4-(2-PYRIDYL)BENZENESULFONAMIDES AND THEIR THERAPEUTIC USE

IPC classification:
A61P 29/00, A61K 31/4418, A61K 31/18, C07C 311/20, C07D 213/61
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14753395

METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS

IPC classification:
A61K 31/225, A61K 31/215, C12Q 1/68, C12Q 1/48
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14772500

CRYSTALLINE FORMS OF (N,N-DIETHYLCARBAMOYL)METHYL METHYL (2E)BUT-2-ENE-1,4-DIOATE, METHODS OF SYNTHESIS AND USE

IPC classification:
A61P 17/06, A61P 3/10, A61P 11/06, A61P 29/00, A61P 31/12, A61P 31/18, A61P 31/22, C07C 235/06, A61P 25/28, A61K 31/225
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14766786

3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61P 35/00, A61K 31/472, A61K 31/4725, C07D 471/08, C07D 413/10, C07D 401/10, C07D 217/24, C07D 413/14, C07D 401/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14781338

LIQUID PROTEIN FORMULATIONS CONTAINING ORGANOPHOSPHATES

IPC classification:
A61K 47/18, A61K 39/00, A61K 9/19, C07K 1/14, A61K 38/00, A61K 47/20, A61K 9/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14781337

LIQUID PROTEIN FORMULATIONS CONTAINING WATER SOLUBLE ORGANIC DYES

IPC classification:
A61K 47/20, A61K 38/00, A61K 9/19, A61K 39/00, A61K 9/00, C07K 1/14, A61K 39/395, A61K 47/18, A61K 9/08
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14846876

PHOSPHORODIAMIDATE BACKBONE LINKAGE FOR OLIGONUCLEOTIDES

IPC classification:
A61P 35/00, A61K 48/00, A61K 31/7125, C12N 15/113, C07H 21/04, C07H 19/20, C07H 19/10
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13783630

DI-ISOPROPYL-PHOSPHINOYL-ALKANE (DAPA) COMPOUNDS AS TOPICAL AGENTS FOR THE TREATMENT OF SENSORY DISCOMFORT

IPC classification:
A61P 17/00, A61P 25/24, A61K 31/662, C07F 9/53
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14860025

POLYNUCLEOTIDE CONSTRUCTS HAVING DISULFIDE GROUPS

IPC classification:
C12P 19/34, C07F 9/02
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14866158

HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE

IPC classification:
A61K 31/4045
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14806358

1 -(5-TERT-BUTYL-2-ARYL-PYRAZOL-3-YL)-3-[2-FLUORO-4-[(3-OXO-4H-PYRIDO[2, 3-B]PYRAZIN-8-YL)OXY]PHENYL]UREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/4985, C07D 471/04
Applicant:
Cancer Research Technology Ltd
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15705417

HETEROARYL AMIDES AS INHIBITORS OF PROTEIN AGGREGATION

IPC classification:
A61P 25/28, A61K 31/4045, C07D 417/14
Applicant:
UCB Biopharma SPRL
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The patent has been granted
EP15706282

PYRAZOLO[1,5-A]PYRIMIDINE-5,7-DIAMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE

IPC classification:
A61P 35/00, A61K 31/519, C07D 487/04
Applicant:
Cancer Research Technology Ltd
Applicant:
Emory University
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15776318

METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF

IPC classification:
A61P 25/00, A61K 31/4245, A61K 31/41, A61K 31/19, C07D 271/06, C07D 257/04, C07C 65/10, C07C 65/05
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15803360

ANTI-HER2 ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE THEREOF

IPC classification:
A61K 47/50, A61K 31/4045
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15806027

METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAMS) AND USES THEREOF

IPC classification:
A61K 31/4196, A61K 31/433, A61K 31/427, A61K 31/426, C07D 249/08, C07D 217/06, C07D 285/08, C07D 417/04, C07D 277/20
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15812491

CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING

IPC classification:
A61K 47/50
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15819578

QUINUCLIDINE COMPOUNDS FOR MODULATING ALPHA7 -NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY

IPC classification:
A61P 25/28, C07D 209/04, C07D 471/08, A61K 31/439, C07D 453/02
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15759570

FUMARATE ANALOGS AND USES THEREOF IN THE TREATMENT OF AN AUTOIMMUNE DISEASE OR AN INFLAMMATORY DISEASE

IPC classification:
A61P 37/00, A61P 17/06, A61K 31/41, C07D 405/06, C07D 405/04, C07D 403/12, C07D 401/04, C07D 257/04
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15836833

NOVEL ULK1 INHIBITORS AND METHODS USING SAME

IPC classification:
A61P 27/00, A61P 35/00, A61K 31/519, A61K 31/517, A61K 31/506, A61K 31/505
Applicant:
Yale University
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15851085

INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF

IPC classification:
C07D 215/02, A61K 31/4706
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15787849

METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR

IPC classification:
A61K 31/33
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15817206

BICYCLOHETEROARYL-HETEROARYL-BENZOIC ACID COMPOUNDS AS RETINOIC ACID RECEPTOR BETA (RAR ) AGONISTS

IPC classification:
A61P 25/02, A61P 25/14, A61P 25/16, A61K 31/41, C07D 417/04, C07D 413/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15877341

COX-2-TARGETING, PLATINUM-CONTAINING CONJUGATES AND THEIR USE IN THE TREATMENT OF TUMORS AND CANCERS

IPC classification:
A61K 47/50
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16700936

METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR

IPC classification:
A61P 29/00, A61P 37/00, A61K 31/473
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16703250

SUBSTITUTED TRIAZOLES AND METHODS RELATING THERETO

IPC classification:
A61P 25/14, A61P 25/08, A61K 31/5377, A61K 31/497, A61K 31/422, A61K 31/4192, C07D 249/04, C07D 405/04, C07D 403/04, C07D 401/12
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP16704973

TETRAZOLONES AS CARBOXYLIC ACID BIOISOSTERES

IPC classification:
C07D 501/46, C07D 498/06, C07D 487/04, C07D 257/04, C07D 471/04, C07J 9/00, C07D 413/10, C07D 403/14, C07D 403/10, C07D 403/06, C07D 403/04, C07D 401/12, C07D 401/04, C07D 401/14, C07D 403/12
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16705684

[9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO-[2,1-A]ISOQUINOLIN-2-YL]METHANOL AND COMPOUNDS, COMPOSITIONS AND METHODS RELATING THERETO

IPC classification:
C07D 455/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15881407

ACTIVATED FORMYLGLYCINE-GENERATING ENZYMES AND METHODS OF PRODUCING AND USING THE SAME

IPC classification:
C12P 21/04, C12P 21/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16704945

NOVEL N-ACYL-ARYLSULFONAMIDE DERIVATIVES AS AMINOACYL-TRNA SYNTHETASE INHIBITORS

IPC classification:
A61P 31/00, A61K 31/18, A61K 31/505, A61K 31/47, A61K 31/4402, C07D 487/04, C07D 251/22, C07D 239/48, C07D 239/47, C07D 239/42, C07C 311/00, C07D 217/22, C07D 215/36, C07D 311/20, C07D 213/71
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15810646

N-(4-HYDROXY-4-METHZL-CYCLOHEXYL)-4-PHENYL-BENZENESULFONAMIDE AND N-(-4HYDROXY-4-METHYL-CYCLOHEXYL)-4-(2-PYRIDYL)-BENZENESULFONAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61P 29/00, A61K 31/4418, A61K 31/18, C07C 311/20, C07D 213/85
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16765550

FIXED DOSE COMBINATIONS AND FORMULATIONS COMPRISING ETC1002 AND EZETIMIBE AND METHODS OF TREATING OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE

IPC classification:
A61K 31/397, A61K 31/194
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16764060

PUSH AND/OR PULL HANDLE LOCKSET

IPC classification:
E05B 55/00, E05B 59/00, E05B 63/22
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16765682

FIXED DOSE COMBINATIONS COMPRISING ETC1002 AND ONE OR MORE STATINS FOR TREATING OR REDUCING CARDIOVASCULAR RISK

IPC classification:
A61P 3/06, A61P 9/10, A61K 31/194
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16721320

5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE

IPC classification:
A61P 25/00, A61K 31/407, C07D 487/06
Agent:
HGF Limited
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP17184430

SYNTHESIS OF PROTECTED 3'-AMINO 5'-PHOSPHORAMIDITE NUCLEOSIDE MONOMERS

IPC classification:
C07H 19/20, C07H 19/10
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP17186099

BIPHENYL-ETHYL-PYRROLIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR MODULATORS FOR THE TREATMENT OF COGNITIVE DISORDERS

IPC classification:
A61P 37/08, A61P 3/04, A61P 25/04, A61P 25/18, A61P 25/24, A61P 25/08, A61P 25/28, A61K 31/41, A61K 31/4025, A61K 31/40, C07D 207/06, C07D 403/10, C07D 401/10, C07D 295/14, C07D 257/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The application has been published
EP16734529

CRYSTALLINE L-ARGININE SALT OF (R)-2-(7-(4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)BENZYLOXY)-1,2,3,4-TETRAHYDROCYCLO-PENTA[B]INDOL-3-YL)ACETIC ACID(COMPOUND1) FOR USE IN SIPI RECEPTOR-ASSOCIATED DISORDERS

IPC classification:
A61P 5/00, A61P 3/00, A61P 7/00, A61P 1/00, A61P 9/00, A61P 35/00, A61P 29/00, A61P 37/00, A61K 31/403, C07D 209/94
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP17195060

MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO

IPC classification:
A61P 3/00, A61K 31/506, C07D 413/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The application has been published
EP16745078

METHODS OF CHEMICAL SYNTHESIS OF SUBSTITUTED 10H-PHENOTHIAZINE-3,7-DIAMINE COMPOUNDS

IPC classification:
C07D 279/20
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16831452

BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION

IPC classification:
C07D 413/12, C07D 417/12, C07D 403/12, A61K 31/404
Applicant:
UCB Biopharma SPRL
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16751083

5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE

IPC classification:
A61P 3/04, A61K 31/55, C07D 491/052, C07D 223/32, C07D 223/16
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP17200625

MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION

IPC classification:
A61P 35/00, C12N 5/00, C07H 21/04, A61K 47/54
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The application has been published
EP17183750

PYRAZOLYL SUBSTITUTED CARBONIC ACID DERIVATIVES AS MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

IPC classification:
A61P 11/00, A61P 9/00, A61K 31/416, A61K 31/4155, A61K 31/415, C07D 409/04, C07D 405/04, C07D 401/04, C07D 231/56, C07D 231/54, C07D 231/18, C07D 231/12
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The application has been published
EP18156929

HETEROARYL AMIDES AS INHIBITORS OF PROTEIN AGGREGATION

IPC classification:
C07D 417/12, C07D 413/12, C07D 403/12, A61P 25/28, A61K 31/4045, C07D 417/14
Applicant:
UCB Biopharma SPRL
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The application has been published
EP18150186

CANNABINOID RECEPTOR MODULATORS

IPC classification:
A61P 19/02, A61P 29/00, C07F 9/09, A61K 31/661, A61K 31/497, A61K 31/4439, A61K 31/416, C07D 405/14, C07D 403/04, C07D 401/14, C07D 401/04, C07D 231/54
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The application has been published
EP16794479

VALBENAZINE SALTS AND POLYMORPHS THEREOF

IPC classification:
A61P 25/00, A61K 31/4375, C07D 471/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16798333

N-[2-(1 -BENZYLPIPERIDIN-4-YL)ETHYL]-4-(PYRAZIN-2-YL)-PIPERAZINE-1 -CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MUSCARINIC RECEPTOR 4 (M4) ANTAGONISTS FOR TREATING NEUROLOGICAL DISEASES

IPC classification:
A61P 25/18, A61P 25/16, A61P 25/28, A61K 31/4545, A61K 31/445, C07D 211/40, C07D 211/26, C07D 401/12
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP18156371

PROCESSES FOR THE PREPARATION OF (R)-2-(7-(4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)BENZYLOXY)-1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOL-3-YL)ACETIC ACID AND SALTS THEREOF

IPC classification:
A61P 37/06, A61P 29/00, A61K 31/403, C07D 209/94
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The application has been published
EP18159738

CANNABINOID RECEPTOR MODULATORS

IPC classification:
A61P 29/00, A61K 31/661, A61K 31/497, A61K 31/4439, A61K 31/416, C07F 9/09, C07D 405/14, C07D 403/04, C07D 401/14, C07D 401/04, C07D 231/54
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The application has been published
EP16873851

POLYNUCLEOTIDE CONSTRUCTS HAVING AN AUXILIARY MOIETY NON-BIOREVERSIBLY LINKED TO AN INTERNUCLEOSIDE PHOSPHATE OR PHOSPHOROTHIOATE

IPC classification:
C12P 19/34, C12N 15/85, C07F 9/02, A61K 31/7088
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16880126

INHIBITORS OF GLUCOCORTICOID RECEPTOR

IPC classification:
A61K 31/58, A61K 31/567, A61K 31/565, C07J 51/00, C07J 43/00, C07J 41/00, C07J 1/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16880121

INHIBITORS OF GLUCOCORTICOID RECEPTOR

IPC classification:
A61K 31/58, A61K 31/567, A61K 31/565, C07J 51/00, C07J 43/00, C07J 41/00, C07J 33/00, C07J 31/00, C07J 1/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP18164225

CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF CONDENSED AZACYCLES (CANNABINOID RECEPTOR MODULATORS)

IPC classification:
A61P 29/00, A61K 31/416, C07D 403/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The application has been published
EP16823529

SYNTHETIC METHODS FOR PREPARATION OF (S)-(2R,3R,11BR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11B-HEXAHYDRO-1H-PYRIDO[2,1,-A]lSOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE)

IPC classification:
C07D 471/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP18164223

ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

IPC classification:
A61P 25/00, A61P 9/10, A61P 7/02, A61K 31/454, A61K 31/427, A61K 31/4192, A61K 31/42, C07D 411/12, C07D 403/12, C07D 231/16, C07D 231/12, C07D 413/12
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The application has been published

Please Sign in to use this feature